Lachlan K L, Lucassen A M, Bunyan D, Temple I K
Wessex Clinical Genetics Service, Southampton University Hospitals Trust, Southampton, UK.
J Med Genet. 2007 Sep;44(9):579-85. doi: 10.1136/jmg.2007.049981. Epub 2007 May 25.
The most commonly reported phenotypes described in patients with PTEN mutations are Bannayan-Riley-Ruvalcaba syndrome (BRRS), with childhood onset, macrocephaly, lipomas and developmental delay, and Cowden Syndrome (CS), an adult-onset condition recognised by mucocutaneous signs, with a risk of cancers, in particular those of the thyroid and breast. It has been suggested that BRRS and CS are the same condition, but the literature continues to separate them and seek a genotype-phenotype correlation.
To study the clinical features of patients with known PTEN mutations and observe any genotype-phenotype correlation.
In total, 42 people (25 probands and 17 non-probands) from 26 families of all ages with PTEN mutations were recruited through the UK clinical genetics services. A full clinical history and examination were undertaken.
We were unable to demonstrate a genotype-phenotype correlation. Furthermore, our findings in a 31-year-old woman with CS and an exon 1 deletion refutes previous reports that whole exon deletions are only found in patients with a BRRS phenotype.
Careful phenotyping gives further support for the suggestion that BRRS and CS are actually one condition, presenting variably at different ages, as in other tumour-suppressor disorders such as neurofibromatosis type 1. This has important counselling implications, such as advice about cancer surveillance, for children diagnosed with BRRS.
在携带PTEN突变的患者中,最常报告的表型是班纳扬-莱利-鲁瓦尔卡瓦综合征(BRRS),其发病于儿童期,有巨头畸形、脂肪瘤和发育迟缓症状;以及考登综合征(CS),这是一种成年发病的疾病,通过皮肤黏膜体征识别,有患癌风险,尤其是甲状腺癌和乳腺癌。有人提出BRRS和CS是同一种疾病,但文献仍将它们分开,并寻求基因型与表型的相关性。
研究已知携带PTEN突变患者的临床特征,并观察是否存在基因型与表型的相关性。
通过英国临床遗传学服务机构,招募了来自26个家庭的42人(25名先证者和17名非先证者),这些人年龄各异且均携带PTEN突变。进行了全面的临床病史采集和检查。
我们无法证明基因型与表型之间存在相关性。此外,我们在一名患有CS且有外显子1缺失的31岁女性中的发现,反驳了之前关于全外显子缺失仅见于具有BRRS表型患者的报道。
细致的表型分析进一步支持了BRRS和CS实际上是同一种疾病的观点,它们在不同年龄表现各异,如同1型神经纤维瘤病等其他肿瘤抑制性疾病一样。这对于癌症监测建议等方面具有重要的咨询意义,比如为被诊断为BRRS的儿童提供相关建议。